Kara Yanoff

Kara Yanoff is a seasoned Rare Disease Territory Manager with extensive experience in the pharmaceutical industry. Currently, at United Therapeutics Corporation since March 2021, Kara specializes in promoting Orenitram and Tyvaso for Pulmonary Arterial Hypertension and has successfully launched Tyvaso for ILD and the Tyvaso Dry Powder Inhaler. Prior to this role, Kara served at Actelion, representing Opsumit and Uptravi, where notable achievements included receiving the Shining Star Award and serving as a district trainer. Experience as a Clinical Specialist at Genentech involved launching the multiple sclerosis medication Ocrevus, consistently exceeding sales quotas. Early career at Glaxo Smith Kline focused on developing physician relationships and marketing various pharmaceutical products. Kara holds degrees in Psychology and Sales Management from Akron University and Kent State University.